Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

GreenPeptide files IND for cancer peptide vaccine GRN-1201

Oct. 8, 2015

MedImmune initiates phase I study of MEDI-9197 for solid tumor cancers

Oct. 8, 2015

FDA places clinical hold on axalimogene filolisbac

Oct. 7, 2015

Biosimilar ONS-1045 meets primary and secondary endpoints in phase I trial

Oct. 7, 2015

Nivolumab shows enhanced overall survival in mRCC patients

Oct. 6, 2015

FDA approves Keytruda and companion diagnostic for PD-L1-expressing NSCLC tumors

Oct. 5, 2015

MedImmune and 3M Drug Delivery Systems collaborate to develop next-generation TLR agonists

Sep. 30, 2015

Advaxis initiates phase I study of ADXS-HER2 for HER2-expressing solid tumors

Sep. 30, 2015

CIRM grants USD 19.9 million to ImmunoCellular for the funding of ICT-107

Sep. 29, 2015

EMA CHMP grants accelerated assessment of Janssen's daratumumab for MM

Sep. 25, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...